52 results
Page 2 of 3
6-K
EX-99.2
gi1qszxk x8dx
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
c5bjug82ov ao4kqkzv
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.2
mgw6m ib78cfm6
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
amke8lef291fmq3b2dn5
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
sm7o4
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
2l7il8xk8hhpiqzhau
19 Feb 21
Pipeline and capital for growth
6:00am
6-K
EX-99.2
p5ryvv2 p6s
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.2
z8zonl8xid7v
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.2
lennzn7
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.2
iv48w6q5mi3i6my7el2
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.2
i7ppondb4hbujv4mn
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
96jhl70j
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
y1r rci6i2
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.2
7v4scm
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm
F-3ASR
wla5a6 tj4jvd1quqjvp
29 Mar 19
Automatic shelf registration (foreign)
5:26pm
6-K
EX-99.2
p5wjdf64im75mv
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm
424B5
w7gz yzlog55v
13 Sep 18
Prospectus supplement for primary offering
12:00am